Flt23k nanoparticles offer additive benefit in graft survival and anti-angiogenic effects when combined with triamcinolone.
about
Corneal gene therapy: basic science and translational perspectiveAAV2 delivery of Flt23k intraceptors inhibits murine choroidal neovascularizationA biodegradable, sustained-released, prednisolone acetate microfilm drug delivery system effectively prolongs corneal allograft survival in the rat keratoplasty modelBMP7 gene transfer via gold nanoparticles into stroma inhibits corneal fibrosis in vivoUnderstanding lymphangiogenesis in knockout models, the cornea, and ocular diseases for the development of therapeutic interventions.Soluble vascular endothelial growth factor receptor 3 is essential for corneal alymphaticity.Nanotechnology approaches for ocular drug delivery.Nanomedicines for back of the eye drug delivery, gene delivery, and imaging.Nanoparticles in the ocular drug delivery.Gene therapy in corneal transplantation.Stem Cell Therapy for Corneal Regeneration Medicine and Contemporary Nanomedicine for Corneal Disorders.Application of lipid nanoparticles to ocular drug delivery.Combination of nanotechnology with vascular targeting agents for effective cancer therapy.Corticosteroid-loaded biodegradable nanoparticles for prevention of corneal allograft rejection in rats.Angiogenesis and lymphangiogenesis in corneal transplantation-A review.Potential lymphangiogenesis therapies: Learning from current antiangiogenesis therapies-A review.
P2860
Q27027504-931CAD69-5D77-411B-9DC4-B70DFB553EEFQ27318539-3FEB139E-FEB2-4E40-A7B2-2C04A46478EAQ28535125-2F8FE4D4-A5E3-4246-8A22-080A430975C8Q31120997-E67936F1-468A-4E74-9976-5344EB882038Q36808641-A2881F95-804D-4DA1-AAA0-5A62C3D92BC5Q36850869-340D1979-92D6-4466-AA8C-BE92A1CA8B4FQ38098509-CF0FD577-0640-47DB-83DC-C2C451B8479BQ38100561-E78FC79D-6E32-4B2F-94F0-BC77C367F4B3Q38119238-4FF6C7FA-D6BF-4DE2-9497-B827C321740AQ38153722-22F413D5-72FF-46A8-9CCD-978FB282B09AQ38288519-D888DC50-EE38-4D61-A354-F78F94510980Q38862505-809F5A70-0085-4C37-966B-7986DFE8F17BQ39368839-5C67A633-4135-4712-A3E7-FB211A248BE8Q41597703-228042C4-9C06-460D-BA9F-39E087863799Q47759308-710EC470-447F-4527-8BC9-31ED76120744Q50419857-7654A2D5-3C0F-4DE2-846C-400ED0FBF03C
P2860
Flt23k nanoparticles offer additive benefit in graft survival and anti-angiogenic effects when combined with triamcinolone.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 30 April 2012
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Flt23k nanoparticles offer add ...... n combined with triamcinolone.
@en
Flt23k nanoparticles offer add ...... n combined with triamcinolone.
@nl
type
label
Flt23k nanoparticles offer add ...... n combined with triamcinolone.
@en
Flt23k nanoparticles offer add ...... n combined with triamcinolone.
@nl
prefLabel
Flt23k nanoparticles offer add ...... n combined with triamcinolone.
@en
Flt23k nanoparticles offer add ...... n combined with triamcinolone.
@nl
P2093
P2860
P356
P1476
Flt23k nanoparticles offer add ...... n combined with triamcinolone.
@en
P2093
Balamurali K Ambati
Bonnie Archer
Hironori Uehara
Jason R Young
Nirbhai Singh
Puneet Tyagi
Uday B Kompella
Xiaohui Zhang
Yang Kyung Cho
P2860
P304
P356
10.1167/IOVS.11-8393
P407
P577
2012-04-30T00:00:00Z